Natures Sunshine Products

Nature's Sunshine Products, a Pharmaceutical Preparation Manufacturing company based in the US, reported its global carbon emissions for 2023. The company's Scope 1 emissions were 1,071,900 kg CO2e, and Scope 2 emissions were 936,300 kg CO2e. Scope 3 emissions for 2023 totalled 41,843,000 kg CO2e, with significant contributions from purchased goods and services (36,070,000 kg CO2e) and downstream transportation and distribution (3,689,000 kg CO2e).

For 2021, Nature's Sunshine Products' total reported emissions were 43,364,000 kg CO2e. This included Scope 1 emissions of 1,246,000 kg CO2e and Scope 2 emissions of 1,992,000 kg CO2e, primarily from purchased electricity. Scope 3 emissions in 2021 amounted to 40,126,000 kg CO2e, with purchased goods and services (33,450,000 kg CO2e) being the largest contributor.

The company has not disclosed any specific, publicly available reduction targets or commitments, such as those recognised by the Science Based Targets initiative (SBTi) or a commitment to The Climate Pledge. All emissions data reported is directly from Nature's Sunshine Products, Inc.